SEC Filings - Supernus Pharmaceuticals

Filing date	Description	Form	Filing Group	View
January 13, 2023	Amendment to a previously filed 4	4/A	3,4,5	View HTML 0001104659-23-003861.pdf 0001104659-23-003861.xls
January 13, 2023	Amendment to a previously filed 4	4/A	3,4,5	View HTML 0001104659-23-003860.pdf 0001104659-23-003860.xls
April 12, 2023	Amendment to a previously filed 4	4/A	3,4,5	View HTML 0001104659-23-044664.pdf 0001104659-23-044664.xls
April 12, 2023	Amendment to a previously filed 4	4/A	3,4,5	View HTML 0001104659-23-044666.pdf 0001104659-23-044666.xls
April 12, 2023	Amendment to a previously filed 4	4/A	3,4,5	View HTML 0001104659-23-044665.pdf 0001104659-23-044665.xls
May 2, 2012	Form of prospectus disclosing information facts events covered in both forms 424B1 424B3	424B4	Registration Statements	View HTML 0001047469-12-005169.pdf 0001047469-12-005169.xls
November 30, 2012	Form of prospectus disclosing information facts events covered in both forms 424B1 424B3	424B4	Registration Statements	View HTML 0001047469-12-010885.pdf 0001047469-12-010885.xls
February 26, 2019	Annual filing director officer or owner of more than ten percent.	5	3,4,5	View HTML 0001104659-19-010791.pdf 0001104659-19-010791.xls
February 8, 2023	Annual filing director officer or owner of more than ten percent.	5	3,4,5	View HTML 0001104659-23-014592.pdf 0001104659-23-014592.xls
April 20, 2012	Registration of certain classes of securities 12(b) of the Securities Exchange Act	8-A12B	Registration Statements	View HTML 0001047469-12-004550.pdf 0001047469-12-004550.xls

Data provided by Kaleidoscope.